Investor Presentaiton

Private large portfolio companies EXTERNALLY VALUED A RETAIL (PHARMACY) BUSINESS OVERVIEW 00 Country's largest retailer in terms of both, revenue and number of bills issued Market share by revenue, 20191 BUSINESSES MAJOR GROWTH DRIVERS GHG in pharma PSP Aversi 336 Other 302 500 615 35% 29% 19% 17% > Expending retail footprint › Enhancing retail margin (private label products) > New retail categories such as lab service and beauty GEORGIA CAPITAL > Growing wholesale revenue (such as hospital supplies) > Digital channels Medium to long-term targets ☐ Double digit revenue CAGR 329 Π 9%+ EBITDA margin Operates under two pharmacy brands, each with a distinct positioning: > GPC for the high-end customer segment > Pharmadepot for the mass retail segment 329 Pharmacies countrywide 226 126 130 61 34 39 102 103 69 25 38 24 9 1 Shopping Areas Clinic Residential area High street Total GPC Pharmadepot Georgia Capital PLC | 1. Total market size 2018 - Frost & Sullivan analysis, revenue distribution between competitors from published audited annual reports 55

View entire presentation